newsfilter
← Latest News
Business Wire·

GDA-501, NAM enabled NK Cell Therapy, Demonstrates Promising Antitumor Activity Against HER2+ Cancers

Preclinical data presented at Society of Immunotherapy of Cancer's 37th Annual Meeting shows proprietary NAM technology expands NK cells, enhances functionality, increases antitumor activity, and improves homing to